Dyslipidemia, Type 2 Diabetes Mellitus
Conditions
Keywords
Management of dyslipidemia in Type 2 Diabetes Mellitus adult patients in India, Dyslipidemia control rates in Type 2 diabetic Mellitus patients
Brief summary
The purpose of study to assess the control of dyslipidemia in the Indian diabetic population treated with any hypolipidemic agent.
Interventions
None listed
Sponsors
AstraZeneca
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult who is a known Type 2 diabetic as per the ADA 2010 criteria OR controlled diabetic (taking any antidiabetic medication) * Patients in the study will have been on lipid lowering drugs at a stable dose for the last three months before the designated study visit.
Exclusion criteria
* Type 1 diabetic patients * Patients with a history of hepatic or renal diseases * Hypertension due to organic diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of type 2 diabetic dyslipidemia patients achieving the target LDL goal according to ADA 2010. These patients should be on stable dose of Lipid Lowering Drugs(LDL) for at least 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of dyslipidemia control rate according to american diabetes Association (ADA) 2010 criteria by age and gender | — |
| Control of dyslipidemia by Lipid Lowering Drugs (LLDs) drugs alone or combination | — |
| Control of dyslipidemia by all commercial available brands hypolipidemics drugs | — |
Outcome results
None listed